Literature DB >> 3036812

Purification and characterization of a 2'-phosphodiesterase from bovine spleen.

M I Johnston, W G Hearl.   

Abstract

Interferon-induced 2',5'-oligoadenylates are transiently produced during viral infection and are believed to play a role in the interferon-mediated inhibition of replication of at least some viruses. 2',5'-Oligoadenylates must be catabolized but are resistant to degradation by most known ribonucleases. A 2'-phosphodiesterase that degrades 2',5'-oligoadenylates was purified 1500-fold from a low speed homogenate of bovine spleen by precipitation at pH 5.2, ammonium sulfate fractionation, differential ultrafiltration, and successive chromatography on DEAE-Sephacel, hydroxylapatite, and a fast protein liquid chromatography Mono P column. No other 2-5A-degrading activity was observed during the purification procedure. The molecular mass of the enzyme estimated by gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis is 65,000. The enzyme is distinct from bovine spleen phosphodiesterase II. The 2'-phosphodiesterase cleaves 2',5'- and 3',5'-linked oligonucleotides, as well as branched oligoadenylate, A(2'pA)(3'pA), but appears to be most active on 3',5'-oligoribonucleotides. The enzyme cleaves 5'-AMP from the 2' terminus of 2',5'-oligoadenylates and appears to require a free 2' terminus and a 3'-oxygen on the penultimate nucleotide. Substrate length, 5'-phosphorylation, and base composition do not appear to be critical factors in determining enzyme activity. The effects of pH, Mg2+, Mn2+, EDTA, phosphate, 2-mercaptoethanol, and N-ethylmaleimide are also described. This enzyme may be involved in the catabolism of the interferon-induced 2',5'-oligoadenylates and other 2',5'-linked RNAs in the cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036812

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist.

Authors:  Kristen M Ogden; Liya Hu; Babal K Jha; Banumathi Sankaran; Susan R Weiss; Robert H Silverman; John T Patton; B V Venkataram Prasad
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

Review 2.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

3.  Regulation of 2',5'-oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor.

Authors:  M A Garcia-Blanco; P Lengyel; E Morrison; C Brownlee; C D Stiles; M Rutherford; G Hannigan; B R Williams
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Crystallization and preliminary X-ray crystallographic analysis of human phosphodiesterase 12.

Authors:  Tetsuya Kohno; Hiroto Yamaguchi; Toshio Hakoshima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-29

5.  Synthesis and biological activities of a phosphorodithioate analog of 2',5'-oligoadenylate.

Authors:  L Beigelman; J Matulic-Adamic; P Haeberli; N Usman; B Dong; R H Silverman; S Khamnei; P F Torrence
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

Review 6.  Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.

Authors:  Robert H Silverman; Susan R Weiss
Journal:  J Interferon Cytokine Res       Date:  2014-06       Impact factor: 2.607

7.  Cloning, sequencing, heterologous expression, and mechanistic analysis of A-74528 biosynthesis.

Authors:  Kathia Zaleta-Rivera; Louise K Charkoudian; Christian P Ridley; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

8.  RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.

Authors:  X L Li; J A Blackford; B A Hassel
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera.

Authors:  P F Torrence; R K Maitra; K Lesiak; S Khamnei; A Zhou; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Authors:  Jian-Qiu Han; Hannah L Townsend; Babal Kant Jha; Jayashree M Paranjape; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.